Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2368 of 6351
-
AI and genes join forces to outsmart rare lymphoma
Knowledge-focused Recruiting nowThe goal of this observational study is to correlate molecular alterations with outcomes including overall survival (OS), progression-free survival (PFS), response rates for patients with a new diagnosis, primary refractory or relapse, of mature T-cell and NK-cell neoplasms (TNKL…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Cancer drug T-DXd safety tracked in ongoing rollover study
Disease control Recruiting nowThis open-label, multicenter, rollover study will provide continued treatment for participants deriving benefit from different therapies received in studies sponsored by Daiichi Sankyo, Inc. (DS) or DS/Astra Zeneca (AZ)-sponsored study (eg. DS8201-A-J101, DS8201-A-U201, DS8201-A-…
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Inhaled antibiotic shows promise for ventilator lung infections
Disease control CompletedArticle: Clinical Outcomes of Inhaled Amikacin in Ventilator-Associated Pneumonia: A group randomized controlled,add-on trial English:Patients in intensive care units often need ventilators to breathe. Sadly, these machines sometimes cause serious lung infections, known as ventil…
Phase 4 • Sponsor: Postgraduate Medical Institute, Lahore • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New breast reconstruction material shows promise in clinical trial
Disease control OngoingThis study is a multicenter, open-label study with both prospective and retrospective components, enrolling up to 120 subjects undergoing breast reconstruction using acellular dermal matrix (ADM). The primary objective of this study is to evaluate differences in complication rat…
Sponsor: DOF Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Prison PTSD therapy shows promise in new study
Symptom relief CompletedStudy examining the psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will be conducted in male and female incarcerated populations and will include 2 groups of individuals for bo…
Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New digital scope could help rectal cancer patients avoid surgery
Diagnosis CompletedThe objective of this prospective international cohort is to evaluate the LUMENEYE rectoscope for assessment on tumor response after total neoadjuvant treatment in rectal cancer. Patients included in this study will be patients who initially will be good candidates for organ pre…
Sponsor: Bordeaux Colorectal Institute Academy • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
New bone graft material could improve spine surgery outcomes
Disease control By invitation onlyThe aim of this study is to evaluate the effectiveness and safety of Natural Matrix Protein™ (NMP™) fibers when used in cervical or lumbar interbody fusion in patients with degenerative disc disease (DDD), spinal stenosis, spondylolisthesis undergoing cervical or lumbar interbody…
Sponsor: Induce Biologics USA Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Hypnosis app shows promise for chronic pain sufferers
Symptom relief CompletedThis ClinicalTrials.gov posting contains two randomized controlled trials. The study procedures were identical, except Study 1 was funded by NIH and enrolled adults with chronic low back pain, whereas Study 2 was funded by the UW Department of Rehabilitation Medicine and enrolled…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New drug trial for duchenne MD halted early – what we know
Disease control Stopped earlyThe study consists of 3 periods: A Screening Period (up to 45 days), a Multiple Ascending Dose (MAD) Period (16 weeks), and a Long-Term Extension (LTE) Period (108 weeks). The primary purpose of the MAD period is to evaluate the safety and tolerability of multiple ascending intr…
Phase 2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Nighttime drug cocktail aims to help seniors sleep better after joint surgery
Symptom relief CompletedSleep disturbances are prevalent in older patients with osteoarthrosis or fracture who are scheduled for knee or hip replacement surgery. The occurrence of sleep disturbances is associated with worse outcomes including increased risk of delirium and cardiac events, and worsened f…
Phase 4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New shot could ease chronic heel pain
Symptom relief CompletedThis study will assess the efficacy, safety, and tolerability of 2 different doses of collagenase clostridium histolyticum (CCH) (previously known as EN3835) compared to placebo.
Phase 2 • Sponsor: Endo USA Inc., a Keenova Therapeutics Company • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Bridging the 'cliff': new clinic model aims to fix broken care for adults with childhood disabilities
Knowledge-focused Recruiting nowThe population cared for in the Transitional and Lifelong Care (TLC) clinic is youth and adults with childhood-onset disability, of which the large majority are adults with brain-based, neurodevelopmental conditions such as cerebral palsy, spina bifida and developmental disabilit…
Sponsor: Western University, Canada • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
8,600-Person study probes contrave heart safety
Disease control OngoingA randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).
Phase 4 • Sponsor: Currax Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New telehealth program aims to ease anxiety in young kids with autism
Symptom relief Recruiting nowAnxiety is prevalent in young children, under 7 years of age, with autism. Yet, few studies have examined anxiety interventions for this age range, and only one anxiety treatment study has included young children with cognitive and language delays. Anxiety treatment models utiliz…
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Brain zapping trial targets 'Rumination' in Tough-to-Treat depression
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if Transcranial Magnetic Stimulation (TMS) to part of the brain called the ventromedial prefrontal cortex (VMPFC) can treat a symptom called rumination in adults with major depression that has not responded to at least one medication tr…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
AI could help match pancreatic cancer patients to the right chemo
Knowledge-focused Recruiting nowTo collect samples and information from patients who will be undergoing standard of care neoadjuvant treatment with either FOLFIRINOX or Gemcitabine + Nab-paclitaxel. The information collected will be used to determine if there are any "biomarkers" in your blood or tumor tissue …
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Exercise program aims to fight frailty in prostate cancer patients
Disease control Recruiting nowThe purpose of this study is to determine whether a 16-week supervised, clinic-based circuit training intervention utilizing resistance and functional exercises and self-directed aerobic exercise will improve frailty and sarcopenic status and disease progression outcomes among pr…
Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Hip labral tear surgery showdown: repair vs. debridement
Disease control CompletedThis study aims to address hip labral tears and compare arthroscopic labral repair versus debridement in non-athletic population aged 20 to 50 years old, including both sexes.
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
AI could make liver tumor treatment more precise
Knowledge-focused Recruiting nowThe endpoint of this study is to develop and validate algorithms, using artificial intelligence and machine learning, to optimize patient selection, treatment planning, treatment evaluation and outcome prediction in patients undergoing thermal ablation of a malignant liver tumor.…
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:41 UTC
-
Prison ADHD drug trial aims to cut recidivism
Disease control Recruiting nowAttention deficit hyperactivity disorder (ADHD) is characterized by difficulties paying attention, poor impulse control, and hyperactive behaviors. It is associated with several health and social detrimental outcomes and leads to increased risks of criminality and recidivism. How…
Phase 3 • Sponsor: Stéphanie Baggio • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC